Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. H.R. 1843. 119th Cong., 1st sess., Introduced in House March 5, 2025. https://www.govinfo.gov/app/details/BILLS-119hr1843ih.
Congress, House of Representatives (2025, March 5). To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. (H.R. 1843 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr1843ih.
United States, Congress, House of Representatives. To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr1843ih. 119th Congress, H.R. 1843, Introduced in House 5 Mar. 2025.
H.R.1843 - 119th Congress (2025-2026): To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications., H.R.1843, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hr1843ih.